MiMedx Group Inc (NASDAQ: MDXG) suffers from significant negative changes in fundamentals: the consensus estimate for December, 2025 decreased significantly, significant quarterly earnings deceleration occurred, and the consensus estimate for December, 2026 decreased significantly.
MiMedx Group Inc (NASDAQ: MDXG) suffers from notable negative changes in investment behavior: negative upside/downside volume developed.
In light of these highly negative signals we are reviewing our current Overall Rating of D. We would continue to view the shares with caution pending completion of this review in the next several days.
Current PriceTarget Research Rating
MiMedx Group has a current Value Trend Rating of D (Negative). This rating combines very contradictory signals from two proprietary PTR measures of a stock’s attractiveness. MiMedx Group has a very low Appreciation Score of 13 but a slightly positive Power Rating of 69, leading to the Negative Value Trend Rating.
Recent Price Action
MiMedx Group Inc (NASDAQ: MDXG) stock declined modestly by -1.4% on 3/7/25. The stock closed at $7.89. This decline was accompanied by normal trading volume. Relative to the market the stock has been exceptionally strong over the last nine months but has declined -3.1% during the last week.
Be the first to comment